-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma names Markus Jensen as chief medical officer, effective Sept. 1, 2026

PUBT·08/10/2026 06:30:24
Listen to the news
Innate Pharma names Markus Jensen as chief medical officer, effective Sept. 1, 2026
  • Innate Pharma named Markus Jensen chief medical officer, effective Sept. 1, 2026, replacing Sonia Quaratino.
  • Jensen joined Innate in 2024 as head of clinical pharmacology, leading global clinical work on key programs including IPH4502.
  • He previously held leadership roles at Bayer for more than 16 years, focused on oncology and clinical development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innate Pharma SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260810961822) on August 10, 2026, and is solely responsible for the information contained therein.